Eirik A. Torheim

An Exploratory Trial of Cyclooxygenase Type 2 Inhibitor in HIV-1 Infection: Downregulated Immune Activation and Improved T Cell-Dependent Vaccine Responses

Frank Olav Pettersen, Eirik A. Torheim, Anders Erik Astrup Dahm et al. · Journal of Virology · 2011 · 66 citations

Life Sciences, Immunology, Pharmacology +17

Increased expression of chemokines in patients with Wegener's granulomatosis − modulating effects of methylprednisolone <i>in vitro</i>

Eirik A. Torheim, Arne Yndestad, Vigdis Bjerkeli et al. · Clinical & Experimental Immunology · 2005 · 28 citations · Full text

Life Sciences, Immunology, Pathology +17

Design of proteolytically stable RI-anchoring disruptor peptidomimetics for <i>in vivo</i> studies of anchored type I protein kinase A-mediated signalling

Eirik A. Torheim, Elisabeth Jarnæss, Birgitte Lygren et al. · Biochemical Journal · 2009 · 27 citations

Life Sciences, Immunology, Medicinal Chemistry +14

Interleukin‐10‐secreting T cells define a suppressive subset within the HIV‐1‐specific T‐cell population

Eirik A. Torheim, Lishomwa C. Ndhlovu, Frank Olav Pettersen et al. · European Journal of Immunology · 2009 · 19 citations · Full text

Life Sciences, Immunology, Infectious Diseases +17

A novel human CD4 ⁺ T‐cell inducer subset with potent immunostimulatory properties

Lishomwa C. Ndhlovu, Fábio E. Leal, Ijeoma Eccles-James et al. · European Journal of Immunology · 2009 · 16 citations · Full text

Life Sciences, Cell Biology, Immunology +16